However, several studies conducted on tissue as well as blood/serum samples have shown that levels of the antioxidant enzyme GPX3 are decreased in a number of human cancers, including breast, gastric, prostrate and colorectal cancer; a seemingly contradictory effect [18-21,28,29]. Here, GPX3 is linked to cancer.